A first-in-human single ascending dose study of a monoclonal antibody against the ANGPTL3/8 complex in subjects with mixed hyperlipidemia
Daniel Gaudet, M. Gonciarz, X. Shen, G. Mullins, J.K. Leohr, O. Benichou, T. Beyer, G. Ruotolo
Topics & Concepts
HyperlipidemiaMonoclonal antibodyMedicineAntibodyInternal medicineImmunologyEndocrinologyDiabetes mellitusLipid metabolism and disordersCancer, Lipids, and MetabolismPeroxisome Proliferator-Activated Receptors